INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1999

Ginkgo biloba extract significantly increased end diastolic velocity in the ophthalmic artery in healthy volunteers.

A Phase I placebo-controlled crossover trial evaluated the effect of Ginkgo biloba extract (GBE) in 11 healthy volunteers treated orally with either 40 mg GBE or placebo three times daily for 2 days, separated by a 2-week washout. GBE significantly increased end diastolic velocity (EDV) in the ophthalmic artery from 6.5 +/- 0.5 to 7.7 +/- 0.5 cm/sec (23% change, p=0.023), with no change seen with placebo (7.2 +/- 0.6 vs 7.1 +/- 0.5 cm/sec, 3% change, p=0.892). GBE did not alter arterial blood pressure, heart rate, or intraocular pressure, and no side effects related to GBE were found.

Study type
Phase I placebo-controlled crossover trial
Who was studied
11 healthy volunteers (8 women, 3 men; age 34 +/- 3 years)
What was measured
Ocular blood flow via color Doppler imaging, blood pressure, heart rate, IOP

THE PAPER

Ginkgo biloba extract increases ocular blood flow velocity.

Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. J Ocul Pharmacol Ther, 1999.

PubMed 10385132 ↗DOI 10.1089/jop.1999.15.233 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.